Ilex Capital Partners (UK) LLP
Position in CRL — Charles River Laboratories International, Inc.
CIK 1985486
London, X0
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,413,760
-$15,479,040 QoQ
Shares Held
81,193
-58.7% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#81
of 564 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ilex Capital Partners (UK) LLP holds $222,464,235 across 5 Diagnostics & Research names. CRL ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
154,736 | $77,578,440 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
370,977 | $71,680,175 | |
| 3 | ILMN |
Illumina, Inc.
|
289,131 | $50,837,903 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
This page
|
81,193 | $18,413,760 | |
| 5 | RVTY |
Revvity, Inc.
|
35,538 | $3,953,957 |
All Filings in CRL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,413,760 | 81,193 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $33,892,800 | 196,480 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,593,254 | 10,585 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||